Literature DB >> 17459360

Measurement of cystine in granulocytes using liquid chromatography-tandem mass spectrometry.

A Chabli1, J Aupetit, M Raehm, D Ricquier, B Chadefaux-Vekemans.   

Abstract

BACKGROUND: Cystinosis is a rare autosomal recessive disorder characterized by an accumulation of intralysosomal cystine due to a defect in cystine transport across the lysosomal membrane. This disorder can be treated specifically using high doses of cysteamine. Accurate measurement of intracellular cystine content is necessary for the diagnosis and monitoring of treatment with cysteamine. Here we describe a new method to measure intracellular cystine. It relies on a liquid chromatography-tandem mass spectrometry assay. We compare this novel method with the cystine-binding protein assay.
METHOD: Cells were isolated and lysed in the presence of N-ethylmaleimide to avoid interference from cysteine. After deproteinization, addition of stable isotope d6 cystine and butylation, cystine was measured using an API 3000 MSMS.
RESULTS: The cystine assay was linear to at least 50 micromol/L. Within-run and between-run coefficients of variation were 2.9% and 5.7% respectively.
CONCLUSION: It is possible to measure very low concentrations of intracellular cystine with liquid chromatography-tandem mass spectrometry. The results obtained with this novel method correlate very well with those obtained using the cystine-binding protein assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459360     DOI: 10.1016/j.clinbiochem.2007.02.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.

Authors:  Koenraad R P Veys; Mohamed A Elmonem; Maria Van Dyck; Mirian C Janssen; Elisabeth A M Cornelissen; Katharina Hohenfellner; Giusi Prencipe; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  J Am Soc Nephrol       Date:  2020-04-09       Impact factor: 10.121

2.  Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy.

Authors:  Adrien Jézégou; Elisa Llinares; Christine Anne; Sylvie Kieffer-Jaquinod; Seana O'Regan; Joëlle Aupetit; Allel Chabli; Corinne Sagné; Cécile Debacker; Bernadette Chadefaux-Vekemans; Agnès Journet; Bruno André; Bruno Gasnier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

Review 3.  Lysosomal diseases: diagnostic update.

Authors:  Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

4.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

5.  Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis.

Authors:  Neveen A Soliman; Mohamed A Elmonem; Lambertus van den Heuvel; Rehab H Abdel Hamid; Mohamed Gamal; Inge Bongaers; Sandrine Marie; Elena Levtchenko
Journal:  JIMD Rep       Date:  2014-01-25

6.  Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.

Authors:  Virginie Janssens; Héloïse P Gaide Chevronnay; Sandrine Marie; Marie-Françoise Vincent; Patrick Van Der Smissen; Nathalie Nevo; Seppo Vainio; Rikke Nielsen; Erik I Christensen; François Jouret; Corinne Antignac; Christophe E Pierreux; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2019-09-23       Impact factor: 10.121

Review 7.  Cystinosis: practical tools for diagnosis and treatment.

Authors:  Martijn J Wilmer; Joost P Schoeber; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

8.  Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.

Authors:  Naïm Bouazza; Jean-Marc Tréluyer; Chris Ottolenghi; Saik Urien; Georges Deschenes; Daniel Ricquier; Patrick Niaudet; Bernadette Chadefaux-Vekemans
Journal:  Orphanet J Rare Dis       Date:  2011-12-23       Impact factor: 4.123

9.  Excellent long-term outcome of renal transplantation in cystinosis patients.

Authors:  Camille Cohen; Marina Charbit; Bernadette Chadefaux-Vekemans; Magali Giral; Valérie Garrigue; Michèle Kessler; Corinne Antoine; Renaud Snanoudj; Patrick Niaudet; Henri Kreis; Christophe Legendre; Aude Servais
Journal:  Orphanet J Rare Dis       Date:  2015-07-25       Impact factor: 4.123

10.  Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis.

Authors:  Mohamed A Elmonem; Samuel H Makar; Lambertus van den Heuvel; Hanan Abdelaziz; Safaa M Abdelrahman; Xavier Bossuyt; Mirian C Janssen; Elisabeth Am Cornelissen; Dirk J Lefeber; Leo Ab Joosten; Marwa M Nabhan; Fanny O Arcolino; Fayza A Hassan; Héloïse P Gaide Chevronnay; Neveen A Soliman; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2014-11-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.